Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
As vaccines are distributed worldwide, we begin to leave behind a tumultuous year that has accelerated many trends and enter into a transition period where markets find equilibrium once again. One area that will continue to have an impact on health provision is the shift towards homecare and greater patient empowerment.
This webinar explored the evidence behind increasing homecare and the role played by the off-patent sector. In addition, updates of high-level market trends in generics, value added medicines and biosimilars were discussed as well as thoughts on what we might expect to see throughout 2021 and beyond.
Engagement Manager, European Thought Leadership
IQVIA
Aurelio creates topical and forward-looking strategic content relevant to pharma executives worldwide and publishes articles, blogs and white papers on a regular basis.
Aurelio’s predominant focus is on off-patent markets where he generates evidence-led insights with a view to spark high-level discourse on biosimilars, generics and value added medicines. Moreover, he is involved in numerous projects exploring the interface between healthcare and digital technology. He is considered a subject matter expert in these areas and speaks at numerous conferences worldwide, presents at board-level meetings and engages in consulting projects.
Prior to IQVIA, Aurelio has worked in Discovery R&D and as a strategy consultant in Life Sciences. He holds an MSci in Chemistry from Imperial College London.
Custom Content Writer
Informa Pharma Intelligence
By completing this form you agree IQVIA may contact you directly about industry news, products, services and events that may be of interest to you subject to their privacy policy.